NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses

Lancet

Volumn 366, Issue 9486, 2005, Pages 649-659

  García Closas, Montserrat ^a   Malats, Núria ^b   Silverman, Debra ^a   Dosemeci, Mustafa ^a   Kogevinas, Manolis ^b   Hein, David W ^c   Tardón, Adonina ^d   Serra, Consol ^e,f   Carrato, Alfredo ^g   García Closas, Reina ^h   Lloreta, Josep ^b,i   Castaño Vinyals, Gemma ^b   Yeager, Meredith ^a   Welch, Robert ^a   Chanock, Stephen ^a   Chatterjee, Nilanjan ^a   Wacholder, Sholom ^a   Samanic, Claudine ^a   Torà, Montserrat ^b   Fernández, Francisco ^b   Real, Francisco X ^b,f   Rothman, Nathaniel ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF OVIEDO   (Spain)

^e Department of Pediatrics   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^h HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; PROTEIN DERIVATIVE; PROTEIN NAT2; UNCLASSIFIED DRUG;

ACETYLATION; ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER RISK; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPAIN; TRANSITIONAL CELL CARCINOMA;

EID: 23844512858     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67137-1     Document Type: Article

References (61)

1. HM Colhoun, PM McKeigue, SG Davey Problems of reporting genetic associations with complex outcomes Lancet 361 2003 865 872
2. P Vineis, D Marinelli, H Autrup Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies Cancer Epidemiol Biomarkers Prev 10 2001 1249 1252
3. A d'Errico, N Malats, P Vineis, P Boffetta Review of studies of selected metabolic polymorphisms and cancer IARC Sci Publ 148 1999 323 393
4. PM Marcus, P Vineis, N Rothman NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population Pharmacogenetics 10 2000 115 122
5. J Green, E Banks, A Berrington, S Darby, H Deo, R Newton N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction Br J Cancer 83 2000 412 417
6. LE Johns, RS Houlston N-acetyl transferase-2 and bladder cancer risk: a meta-analysis Environ Mol Mutagen 36 2000 221 227
7. LE Johns, RS Houlston Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis Mutagenesis 15 2000 399 404
8. L Engel, E Taioli, R Pfeiffer Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review Am J Epidemiol 156 2002 95 109
9. A d'Errico, E Taioli, X Chen Genetic metabolic polymorphisms and the risk of cancer: a review of the literature Biomarkers 1 1996 149 173
10. Silverman DT, Devesa SS, Moore LE, Rothman N, Bladder cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press (in press)
11. PM Marcus, RB Hayes, P Vineis Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction Cancer Epidemiol Biomarkers Prev 9 2000 461 467
12. P Vineis, R Pirastu Aromatic amines and cancer Cancer Causes Control 8 1997 346 355
13. DW Hein Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis Mutat Res 506-507 2002 65 77
14. JA Taylor, DM Umbach, E Stephens The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction Cancer Res 58 1998 3603 3610
15. I Cascorbi, I Roots, J Brockmoller Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10 Cancer Res 61 2001 5051 5056
16. H Okkels, T Sigsgaard, H Wolf, H Autrup Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking Cancer Epidemiol Biomarkers Prev 6 1997 225 231
17. RJ Hung, P Boffetta, P Brennan GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population Int J Cancer 110 2004 598 604
18. FI Hsieh, YS Pu, HD Chern, LI Hsu, HY Chiou, CJ Chen Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer Br J Cancer 81 1999 537 541
19. R Jaskula-Sztul, W Sokolowski, M Gajecka, K Szyfter Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk J Appl Genet 42 2001 223 231
20. S Sanyal, F Festa, S Sakano Polymorphisms in DNA repair and metabolic genes in bladder cancer Carcinogenesis 25 2004 729 734
21. GA Toruner, C Akyerli, A Ucar Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population Arch Toxicol 75 2001 459 464
22. DS Srivastava, A Kumar, B Mittal, RD Mittal Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India Arch Toxicol 78 2004 430 434
23. J Brockmoller, I Cascorbi, R Kerb, I Roots Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk Cancer Res 56 1996 3915 3925
24. WJ Kim, H Kim, CH Kim GSTT1-null genotype is a protective factor against bladder cancer Urology 60 2002 913 918
25. E Schnakenberg, R Breuer, R Werdin, K Dreikorn, W Schloot Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer Cytogenet Cell Genet 91 2000 234 238
26. JH Jong, KH Jin, S Young Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers Cancer Lett 202 2003 193 199
27. WJ Kim, HL Lee, SC Lee, YT Kim, H Kim Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis J Urol 164 2000 209 213
28. X Giannakopoulos, K Charalabopoulos, D Baltogiannis The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer Anticancer Res 22 2002 3801 3804
29. SJ Lee, SH Cho, SK Park Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk Cancer Lett 177 2002 173 179
30. LE Moore, JK Wiencke, MN Bates, S Zheng, OA Rey, AH Smith Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina Cancer Lett 211 2004 199 207
31. T Katoh, H Inatomi, H Kim, M Yang, T Matsumoto, T Kawamoto Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk Cancer Lett 132 1998 147 152
32. LW Harries, MJ Stubbins, D Forman, GC Howard, CR Wolf Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer Carcinogenesis 18 1997 641 644
33. QW Ma, GF Lin, JG Chen, JH Shen Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer Biomed Environ Sci 15 2002 253 260
34. J Gu, D Liang, Y Wang, C Lu, X Wu Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians Mutat Res 581 2005 97 104
35. MR Karagas, S Park, A Warren Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study Cancer Lett 219 2005 63 69
36. JI Epstein, MB Amin, VR Reuter, FK Mostofi The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder Am J Surg Pathol 22 1998 1435 1448
37. BR Parker, M Yeager, B Staats SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes Nucleic Acids Res 3 2004 (D528-32)
38. DW Hein, DM Grant, E Sim Update on consensus arylamine N-acetyltransferase gene nomenclature Pharmacogenetics 10 2000 291 292
39. Arylamine N-acetyltransferase nomenclature committee Arylamine N-Acetyltransferase (NAT) nomenclature Available at Available at www.louisville.edu/medschool/pharmacology/NAT.html (accessed May 23, 2005)
40. F Ali-Osman, O Akande, G Antoun, JX Mao, J Buolamwini Molecular cloning,.characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants: evidence for differential catalytic activity of the encoded proteins J Biol Chem 272 1997 10004 10012
41. Chatterjee N, Carroll RJ. Semiparametric maximum likelihood estimation exploiting gene-environment independence in case-control studies. Biometrika (in press)
42. KM Smits, S Benhamou, S Garte Association of metabolic gene polymorphisms with tobacco consumption in healthy controls Int J Cancer 110 2004 266 270
43. S Garte, L Gaspari, A-K Alexandrie Metabolic gene polymorphism frequencies in control populations Cancer Epidemiol Biomarkers Prev 10 2001 1239 1248
44. WD Thompson Effect modification and the limits of biological inference from epidemiologic data J Clin Epidemiol 44 1991 221 232
45. DW Hosmer, S Lemeshow Confidence interval estimation of interaction Epidemiology 3 1992 452 456
46. NM Laird, F Mosteller Some statistical methods for combining experimental results Int J Technol Assess Health Care 6 1990 5 30
47. CB Begg, M Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
48. M Egger, SG Davey, M Schneider, C Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
49. DM Umbach, CR Weinberg Designing and analysing case-control studies to exploit independence of genotype and exposure Stat Med 16 1997 1731 1743
50. H Tsukino, H Nakao, Y Kuroda Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking Eur J Cancer Prev 13 2004 509 514
51. RD Mittal, DS Srivastava, A Mandhani NAT2 gene polymorphism in bladder cancer: a study from North India Clin Urol 30 2004 279 288
52. D Aktas, H Ozen, N Atsu, A Tekin, S Sozen, E Tuncbilek Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer? Cancer Genet Cytogenet 125 2001 1 4
53. C Steinhoff, KH Franke, K Golka Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma Arch Toxicol 74 2000 521 526
54. H Bartsch, C Malaveille, M Friesen, FF Kadlubar, P Vineis Black (air-cured) and blond (flue-cured) tobacco cancer risk: IV, molecular dosimetry studies implicate aromatic amines as bladder carcinogens Eur J Cancer 29A 1993 1199 1207
55. JD Hayes, RC Strange Glutathione S-transferase polymorphisms and their biological consequences Pharmacology 61 2000 154 166
56. HP Hanssen, DP Agarwal, HW Goedde Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis: study in a north German population Eur Urol 11 1985 263 266
57. A Kaisary, P Smith, E Jaczq Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors Cancer Res 47 1987 5488 5493
58. H Inatomi, T Katoh, T Kawamoto, T Matsumoto NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese Int J Urol 6 1999 446 454
59. I Georgiou, IF Filiadis, Y Alamanos, I Bouba, X Giannakopoulos, D Lolis Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study Eur Urol 37 2000 660 664
60. JD Hayes, DJ Pulford The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit Rev Biochem Mol Biol 30 1995 445 600
61. AC Deitz, N Rothman, TR Rebbeck Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer Cancer Epidemiol Biomarkers Prev 13 2004 1543 1546